These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 7636977)

  • 1. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
    Henderson AJ; Zou X; Calame KL
    J Virol; 1995 Sep; 69(9):5337-44. PubMed ID: 7636977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
    Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
    J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
    Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
    J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
    J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
    Burdo TH; Gartner S; Mauger D; Wigdahl B
    J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
    Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
    Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.
    Honda Y; Rogers L; Nakata K; Zhao BY; Pine R; Nakai Y; Kurosu K; Rom WN; Weiden M
    J Exp Med; 1998 Oct; 188(7):1255-65. PubMed ID: 9763605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
    J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
    Dahiya S; Liu Y; Nonnemacher MR; Dampier W; Wigdahl B
    PLoS One; 2014; 9(2):e88116. PubMed ID: 24551078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.
    Schwartz C; Catez P; Rohr O; Lecestre D; Aunis D; Schaeffer E
    J Virol; 2000 Jan; 74(1):65-73. PubMed ID: 10590092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
    Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
    J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.
    Nonnemacher MR; Hogan TH; Quiterio S; Wigdahl B; Henderson A; Krebs FC
    Biomed Pharmacother; 2003 Jan; 57(1):34-40. PubMed ID: 12642035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
    Ambrosino C; Ruocco MR; Chen X; Mallardo M; Baudi F; Trematerra S; Quinto I; Venuta S; Scala G
    J Biol Chem; 1997 Jun; 272(23):14883-92. PubMed ID: 9169458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.
    Henderson AJ; Connor RI; Calame KL
    Immunity; 1996 Jul; 5(1):91-101. PubMed ID: 8758898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
    Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.